Symptom-centric view
Product dose omission issue
Substances reporting Product dose omission issue disproportionately — ranked by ROR.
showing 4 of 4
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tirzepatide Mounjaro · Zepbound | 2.3 [2.2–2.4] | 4,162 | glp-1 | new |
| 2.9 [2.7–3.2] | 429 | algemeen | new | |
| 7.2 [6.9–7.5] | 2,175 | algemeen | new | |
| 4.3 [4.0–4.6] | 847 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).